Optimal techniques for arterial gene transfer

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 391-404

  Feldman, Laurent J ^a   Steg, Gabriel ^a  

^a INSERM   (France)

Author keywords

Adenovirus; Angiogenesis; Atherosclerosis; Catheter; Gene therapy; Liposomes; Plaque stabilization; Restenosis

Indexed keywords

LIPOSOME; PLASMID DNA; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; GENE TRANSFER; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; SWINE; TRANSGENE;

ARTERIES; ARTERIOSCLEROSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0030729072     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00148-X     Document Type: Review

References (141)

1. Cooper ES Prevention: The key to progress. Circulation. 24:1993;629-632.
2. Ross R The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
3. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N Vascular biology and medicine in the 1990s: Scope, concepts, potentials, and perspectives. Circulation. 87:1993;705-719.
4. Gibbons GH, Dzau VJ Molecular therapies for vascular diseases. Science. 272:1996;689-693.
5. Nabel EG Gene therapy for cardiovascular disease. Circulation. 91:1995;541-548.
6. Isner JM, Feldman LJ Gene therapy for arterial disease. Lancet. 344:1994;1653-1654.
7. Danos O, Mulligan RC Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 85:1988;6460-6464.
8. Mulligan RC The basic science of gene therapy. Science. 260:1993;926-932.
9. Nabel EJ, Plautz G, Boyce DM, Stanley JC, Nabel GJ Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 244:1989;1342-1344.
10. Nabel EG, Plautz G, Nabel GJ Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 249:1990;1285-1288.
11. Plautz G, Nabel EG, Nabel GJ Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation. 83:1991;578-583.
12. Weiss R, Taylor C Retrovirus receptors. Cell. 82:1995;531-533.
13. Miller DG, Adam MA, Miller AD Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 10:1990;4239-4242.
14. O'Brien ER, Alpers CE, Stewart DKet al. Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
15. Pickering JG, Weir L, Jekanowski J, Kearney M, Isner JM Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 91:1993;1469-1480.
16. Naldini L, Blömer U, Gallay Pet al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
17. Friedman T, Yee J-K Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med. 1:1995;275-277.
18. Horwitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM, eds. Fundamental Virology. New-York: Raven Press, 1991:771-813.
19. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW, ed. Vaccines: New Approaches to Immunological Problems. Boston, MA: Butterworth-Heinemann, 1992:363-390.
20. Wilson JM Adenoviruses as gene-delivery vehicles. N Engl J Med. 334:1996;1185-1187.
21. Rosenfeld MA, Siegfried W, Yoshimura Ket al. Adenovirus-mediated transfer of a recombinant a1-antitrypsin gene to the lung epithelium in vivo. Science. 252:1991;431-434.
22. Jaffe HA, Danel C, Longenecker Get al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1:1992;372-378.
23. Quantin B, Stratford-Perricaudet LD, Tajbakhsh S, Mandel J-L Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA. 89:1992;2581-2584.
24. Le Gal La Salle G, Robert JJ, Berrard Set al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
25. Ragot T, Vincent N, Chafey Pet al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 361:1993;647-650.
26. French BA, Mazur W, Geske RS, Bolli R Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation. 90:1994;2414-2424.
27. Berkner KL Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol. 158:1992;39-66.
28. Lemarchand P, Jones M, Yamada I, Crystal RG In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 72:1993;1132-1138.
29. Steg PG, Feldman LJ, Scoazec J-Yet al. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 90:1994;1648-1656.
30. Feldman LJ, Steg PG, Zheng LPet al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest. 95:1995;2662-2671.
31. Smith TA, Mehaffey MG, Kayda DBet al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5:1993;397-402.
32. Wang Q, Finer MH Second-generation adenovirus vectors. Nature Med. 2:1996;714-716.
33. Tripathy SK, Black HB, Goldwasser E, Leiden JM Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2:1996;545-550.
34. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA. 91:1994;4407-4411.
35. Yang Y, Ertl HCJ, Wilson JM MHC class I-restricted cytotxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1:1994;433-442.
36. Schulick AH, Newman KD, Virmani R, Dichek DA In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation. 91:1995;2407-2414.
37. Feldman LJ, Pastore CJ, Aubailly Net al. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors. Gene Ther. 4:1997;189-198.
38. Newman KD, Dunn PF, Owens JWet al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 96:1995;2955-2965.
39. Ueno H, Li J-J, Tomita Het al. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol. 15:1995;2246-2253.
40. Van Ginkel F, Liu C, Simecka Jet al. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Human Gene Ther. 6:1995;895-903.
41. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 90:1992;626-630.
42. Vilquin J-T, Guérette B, Kinoshita Iet al. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Human Gene Ther. 6:1995;1391-1401.
43. Engelhardt JF, Ye X, Doranz B, Wilson JM Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 91:1994;6196-6200.
44. Yeh P, Dedieu J-F, Orsini C, Vigne E, Denefle P, Perricaudet P Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol. 70:1996;559-565.
45. Qazilbash M, Young N, Liu J Vectors and target cells for gene therapy of blood diseases. Trends Cardiovasc Med. 6:1996;25-30.
46. Ledley F Non-viral gene therapy. Curr Opin Biotechnol. 5:1994;626-636.
47. Isner JM, Walsh K, Symes Jet al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 91:1995;2687-2691.
48. Isner JM, Pieczek A, Schainfield Ret al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 348:1996;370-374.
49. Felgner PL, Ringold GM Cationic liposome-mediated transfection. Nature. 337:1989;387-388.
50. Takeshita S, Gal D, Leclerc Get al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest. 93:1994;652-661.
51. Lim CS, Chapman GD, Gammon JBet al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation. 83:1991;2007-2011.
52. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 90:1992;936-944.
53. Zhu N, Liggit D, Liu Y, Debs R Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
54. Michael SI, Curiel DT Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1:1994;223-232.
55. Wilson JM, Grossman M, Wu CH, Chowdhury NR, Wu GY, Chowdhury JR Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low-density lipoprotein receptor-deficient rabbits. J Biol Chem. 267:1992;963-967.
56. Curiel DT, Agarwal S, Wagner E, Cotten M Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA. 88:1991;8850-8854.
57. Wagner E, Zatloukal K, Cotten Met al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA. 89:1992;6099-6103.
58. Gao L, Wagner E, Cotten Met al. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Human Gene Ther. 4:1994;17-24.
59. Morishita R, Gibbons G, Kaneda Y, Ogihara T, Dzau V Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest. 91:1993;2580-2585.
60. Dzau VJ, Mann MJ, Morishita R, Kaneda Y Fusigenic viral liposomes for gene therapy in cardiovascular diseases. Proc Natl Acad Sci USA. 93:1996;11421-11425.
61. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension. 21:1993;894-899.
62. von der Leyen HE, Gibbons GH, Morishita Ret al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 92:1995;1137-1141.
63. Morishita R, Gibbons GH, Ellison KEet al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 93:1994;1458-1464.
64. Morishita R, Gibbons GH, Horiuchi Met al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA. 92:1995;5855-5859.
65. Guzman R, Lemarchand P, Crystal RG, Epstein SE, Finkel T Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 88:1993;2838-2848.
66. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 73:1993;797-807.
67. Riessen R, Isner JM Prospects for site-specific delivery of pharmacologic and molecular therapies. J Am Coll Cardiol. 23:1994;1234-1244.
68. Lincoff AM, Topol EJ, Ellis SG Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation. 90:1994;2070-2084.
69. Mitchel JF, Fram DB, Palme II DFet al. Enhanced Intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation. 91:1995;785-793.
70. Camenzind E, Kint P-P, Di Mario Cet al. Intracoronary heparin delivery in humans: Acute feasibility and long-term results. Circulation. 92:1995;2463-2472.
71. Tahlil O, Brami M, Feldman LJ, Branellec D, Steg PG The dispatch catheter as a delivery tool for arterial gene transfer. Cardiovasc Res. 33:1997;181-187.
72. Fram DB, Aretz T, Azrin MAet al. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol. 23:1994;1570-1577.
73. Steg PG, Spaulding C, Makowski S, Feldman LJ, Barry JJ A double blind randomized trial of hydrogel balloon delivery of urokinase during primary angioplasty for acute myocardial infarction. Circulation. 92(I):1995;543. abstract.
74. Wolinsky H, Thung SN Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol. 15:1990;475-481.
75. Lambert CR, Leone JE, Rowlands SM Local drug delivery catheters: Functional comparisson of porous and microporous designs. Cor Art Dis. 4:1993;469-475.
76. Hong MK, Wong SC, Farb Aet al. Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Cor Art Dis. 4:1993;1023-1027.
77. Fernandez-Ortiz A, Meyer BJ, Mailhac Aet al. A new approach for local intravascular drug delivery: Iontophoretic balloon. Circulation. 89:1994;1518-1522.
78. Fischman D, Leon M, Baim Det al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
79. Serruys PW, de Jaegere P, Kiemeneij Fet al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
80. Muller DWM, Topol EJ Implantable devices in the coronary artery: From metal to genes. Trends Cardiovasc Med. 1:1991;225-232.
81. van der Giessen WJ, Serruys PW, Visser WJ Endothelialization of intravascular stents. J Intervent Cardiol. 1:1988;109-120.
82. Scott NA, Candal FJ, Robinson KA, Ades EW Seeding of intracoronary stents with immortalized human microvascular cells. Am Heart J. 129:1995;860-866.
83. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 80:1989;1347-1353.
84. Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res. 70:1992;348-354.
85. Lambert TL, Dev V, Rechavia E, Forrester JS, Litvack F, Eigler NL Localized arterial wall drug delivery from a polymer-coated removable metallic stent: Kinetics, distribution, and bioactivity of forskolin. Circulation. 90:1994;1003-1011.
86. Murphy JG, Schwartz RS, Huber KC, Holmes DR Polymeric stents: Modern alchemy or the future. J Invasive Cardiol. 3:1991;144-148.
87. Dev V, Zeng H, Forrester JSet al. Microspheres for drug delivery to the arterial wall: A study of kinetics, toxicity, and effects of corticosteroid loaded microspheres. J Am Coll Cardiol. 23:1994;19A. abstract.
88. Slepian MJ, Sawhney A, Pathak CPet al. In situ photo-polymerized thin hydrogel barriers applied following arterial injury reduce intimal thickening. J Am Coll Cardiol. 23:1994;473A. abstract.
89. Edelman ER, Adams DH, Karnovsky MJ Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA. 87:1990;3773-3777.
90. Indolfi C, Avvedimento EV, Rapacciuolo Aet al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1:1995;541-545.
91. Simons M, Edelman ER, DeKeyser J-L, Langer R, Rosenberg RD Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 359:1992;67-70.
92. Wolff JA, Malone RW, Williams Pet al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
93. Buttrick PM, Kass A, Kitsis RN, Kaplan ML, Leinwand LA Behavior of genes directly injected into the rat heart in vivo. Circ Res. 70:1992;193-198.
94. von Harsdorf R, Schott R, Shen Y-T, Vatner S, Mahdavi V, Nadal-Ginard B Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals. Circ Res. 72:1993;688-695.
95. Tsurumi Y, Takeshita S, Chen Det al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94:1996;3281-3290.
96. Guzman R, Lemarchand P, Crystal R, Epstein S, Finkel T Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 73:1993;1202-1207.
97. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:1994;51-58.
98. Giordano FJ, Ping P, McKirnan MDet al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2:1996;534-539.
99. Logeart D, Hatem SN, Inamo J, Haddada H, Perricaudet M, Mercadier JJ Increased efficiency of gene transfer to cardiac myocytes with recombinant adenovirus by altering the endothelial barrier permeability. Circulation. 94(I):1996;590. abstract.
100. Wilson JM, Birinyi LK, Salomon RN, Libby P, Callow AD, Mulligan RC Implantation of vascular grafts lined with genetically modified endothelial cells. Science. 244:1989;1344-1346.
101. Chen S-J, Wilson JM, Muller DWM Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation. 89:1994;1922-1928.
102. Flugelman MY, Jaklitsch MT, Newman KD, Casscells W, Brathauer GL, Dichek DA Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 85:1992;1110-1117.
103. Chapman GD, Lim CS, Gammon RSet al. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res. 71:1992;27-33.
104. Riessen R, Rahimizadeh H, Takeshita S, Gal D, Barry JJ, Isner JM Successful vascular gene transfer using a hydrogel coated balloon angioplasty catheter. Human Gene Ther. 4:1993;749-758.
105. Losordo DW, Pickering JG, Takeshita Set al. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Circulation. 89:1994;785-792.
106. Nabel EJ, Yang Z, Liptay Set al. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 91:1993;1822-1829.
107. Nabel EG, Shum L, Pompili VJet al. Direct gene transfer of transforming growth factor β1 into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
108. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA. 91:1994;10732-10736.
109. Chang MW, Barr E, Seltzer Jet al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
110. Chang MW, Barr E, Lu MM, Barton K, Leiden JM Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 96:1995;2260-2268.
111. Schulick AH, Dong G, Newman KD, Virmani R, Dichek DA Endothelium-specific in vivo gene transfer. Circ Res. 77:1995;475-485.
112. Willard JE, Landau C, Glamann DBet al. Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 89:1994;2190-2197.
113. Muller DWM, Gordon D, San Het al. Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res. 75:1994;1039-1049.
114. French BA, Mazur W, Ali NMet al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 90:1994;2402-2413.
115. Rome JJ, Shayani V, Flugelman MYet al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 14:1994;148-161.
116. Ohno T, Gordon D, San Het al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:1994;781-784.
117. Maillard L, Ziol M, Le Feuvre Cet al. Improved efficiency of percutaneous adenoviral-mediated arterial gene transfer by pre-treatment with elastase. J Am Coll Cardiol. 27:1996;255A. abstract.
118. Casscells W, Willerson JT Amphotropic but not atherotropic: Another caveat for adenoviral gene therapy. J Clin Invest. 95:1995;2425-2426.
119. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells following balloon injury. Circulation, in press.
120. March K, Madison JE, Trapnell BC Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by Poloxamer 407 and implications for cardiovascular gene therapy. Human Gene Ther. 6:1995;41-53.
121. March KL, Gradus-Pizlo I, Wilensky RL, Yei S, Trapnell BC Cardiovascular gene therapy using adenoviral vectors: distant transduction following local delivery using a porous balloon catheter. J Am Coll Cardiol. 23:1994;177A. abstract.
122. Wilson JM A pharmacologic rheostat for gene therapy. Nature Med. 2:1996;977-978.
123. Rivera VM, Clackson T, Natesan Set al. A humanized system fpr pharmacologic control of gene expression. Nature Med. 2:1996;1028-1032.
124. Bohl D, Naffakh N, Heard J-M Long-term control of erythropoietin secretion by doxyxycline in mice transplanted with engineered primary myoblasts. Nature Med. 3:1997;299-305.
125. Mikawa T, Hyer J, Itoh N, Wei Y Retroviral vectors to study cardiovascular development. Trends Cardiovasc Med. 6:1996;79-86.
126. Wilson JM Animal models of human disease for gene therapy. J Clin Invest. 97:1996;1138-1141.
127. Muller DW, Ellis SG, Topol EJ Experimental models of coronary artery restenosis. J Am Coll Cardiol. 19:1992;418-432.
128. Feldman LJ, Tahlil O, Steg PG Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc Res. 32:1996;194-207.
129. Feldman LJ, Isner JM Gene therapy for the vulnerable plaque. J Am Coll Cardiol. 26:1995;826-835.
130. Lafont A, Guérot C, Lemarchand P Prospects for gene therapy in cardiovascular disease. Eur Heart J. 17:1996;1312-1317.
131. Clowes AW, Reidy MA, Clowes MM Mechanisms of stenosis after arterial injury. Lab Invest. 49:1983;208-215.
132. Bauters C, Meurice T, Hamon M, McFadden E, Lablanche J-M, Bertrand ME Mechanisms and prevention of restenosis: From experimental models to clinical practice. Cardiovasc Res. 31:1996;835-846.
133. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 76:1995;996-1002.
134. Mintz GS, Popma JJ, Pichard ADet al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation. 94:1996;35-43.
135. Gibbons GH, Dzau VJ The emerging concept of vascular remodeling. N Engl J Med. 330:1994;1431-1438.
136. Scott NA, Cipolla GD, Ross CEet al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary artery. Circulation. 93:1996;2178-2187.
137. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A Adventitial remodeling after coronary arterial injury. Circulation. 93:1996;340-348.
138. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 94:1996;1655-1664.
139. Hoffmann R, Dussaillant GRet al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 94:1996;1247-1254.
140. Lafont A, Guerot C, Lemarchand P Which gene for which restenosis? Lancet. 346:1995;1442-1443.
141. Van Belle E, Maillard L, Couffinhal T, Branellec D, Barry JJ, Feldman LJ Successful percutaneous adenovirus-mediated gene transfer performed during stent implantation. Circulation. 94(I):1996;259. abstract.